{
    "2021-03-18": [
        [
            {
                "time": "2023-10-05",
                "original_text": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. - ABBV",
                "features": {
                    "keywords": [
                        "SHAREHOLDER ALERT",
                        "Pomerantz Law Firm",
                        "Investigates Claims",
                        "AbbVie Inc.",
                        "ABBV"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "ETF looks to help private sector address women’s issues",
                "features": {
                    "keywords": [
                        "ETF",
                        "private sector",
                        "women’s issues"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "social impact"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie (ABBV) Down as FDA Extends Review of Rinvoq sNDA",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "ABBV",
                        "FDA",
                        "Extends Review",
                        "Rinvoq",
                        "sNDA"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Pharma Stock Roundup: J&J, AZN COVID-19 Update, FDA Delays Decision on ABBV's sNDA",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "Roundup",
                        "J&J",
                        "AZN",
                        "COVID-19",
                        "Update",
                        "FDA",
                        "Delays Decision",
                        "ABBV",
                        "sNDA"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}